Elizabeth Campbell
Hematology & Oncology · Cary, NCNPI 1871533315
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $590 and has fallen 64.7% since, to $208 in 2021. That places this record below the midpoint for hematology & oncology clinicians in NC, where the typical reported total is $1,703.
Across 78 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$171
- Pfizer$124
- Puma Biotechnology, Inc.$115
- AbbVie$110
- AstraZeneca$107
- Sanofi$77
- plus $628 from 23 others
What the payments were for
- Food & beverage$1,30898%
- Education$242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 12 | $171 |
| Pfizer | 9 | $124 |
| Puma Biotechnology, Inc. | 8 | $115 |
| AbbVie | 1 | $110 |
| AstraZeneca | 6 | $107 |
| Sanofi | 4 | $77 |
| Novartis | 4 | $63 |
| Lilly USA, LLC | 3 | $51 |
| Amgen | 3 | $49 |
| Eisai Inc. | 3 | $47 |
| Bristol Myers Squibb | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Tersera Therapeutics LLC | 2 | $40 |
| Merck | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Karyopharm Therapeutics Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Tesaro, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| GSK | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Epizyme, Inc. | 1 | $15 |
| EMD Serono, Inc. | 1 | $13 |
| Seagen Inc. | 1 | $13 |
| Exelixis Inc. | 1 | $13 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
| Verastem, Inc. | 1 | $13 |
| Mylan Institutional Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclexta$110
How this compares
$1,332 in reported general payments places this provider in the 45th percentile of 358 hematology & oncology providers in North Carolina.
Other hematology & oncology in Cary
- Amit MehtaCary$4.3M
- Michael MorseDurham$2.6M
- Shelbi AtrashCharlotte$994K
- Phillip FebboDurham$749K
- Angela AlistarWinston Salem$509K
- Ravi PaluriWinston Salem$314K
- Matthew McKinneyDurham$277K
- Jared WeissChapel Hill$217K
- Joshua ZeidnerChapel Hill$208K
- Taewoong ChoiDurham$207K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.